Skip to site menu Skip to page content

Daily Newsletter

16 August 2023

Daily Newsletter

16 August 2023

Hasiya Bayero Paediatric Hospital reopens in Kano, Nigeria

The reopened 86-bed facility aims to address high infant morbidity and mortality rates in the state.

August 14 2023

Kano state Governor Abba Yusuf has officially reopened the Hasiya Bayero Paediatric Hospital in Kano, Nigeria, which was reportedly sold by the previous administration.

Established in 1990, the 33-year old hospital had been sold to an individual during the previous administration, but the present government revoked the sale in June.

The reopened 86-bed facility aims to address high infant morbidity and mortality rates in the state by providing essential medical services, including general paediatric consultations, outpatient care, immunisation, nutritional services, research, training, and referrals.

Governor stated: “I believe that the recovery of this will reduce the burden of medical and surgical healthcare challenges for the good people of Kano State, especially our dear children who are vulnerable to all sorts of diseases.”

According to the The News Nigeria, the facility will provide free maternal healthcare services.

Emir of Kano, Aminu Ado Bayero said: “It has been rendering essential services to our children, especially the less privileged.

“We are most grateful for reviving it while we are calling on all concerns and the citizens of the state to lend hands to the government to succeed.

“We believe the good heart and intentions of the Governor god gave him the ability to do this. We pray that God continues to protect and guide him to do more.”

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close